Flurbiprofen
(Ansaid, Ocufen)
Category:
Description:
Indications:
-
Rheumatoid
arthritis, osteoarthritis, ankylosing spondylitis
-
Inhibition
of inoperative miosis (ophth), cystoid macular edema (non-FDA
approved)
-
Inflammation
after cataract or glaucoma laser surgery or uveitis syndromes (ophth:
non-FDA approved)
-
Bursitis,
primary dysmenorrhea, tendinitis, acute gout (all non-FDA approved)
Contraindications:
Precautions:
-
Pregnancy
category C; excreted in breast milk; use caution in nursing mothers
-
Bleeding
tendencies, peptic ulcer
-
Hepatic/renal
function impairment, elderly, CHF, hypertension
Adverse
Reactions (Side Effects):
-
CNS:
dizziness, headache, lightheadedness
-
CV:
chest pain, CHF, dysrhythmias, edema, hyper/hypotension, palpitation,
tachycardia
-
EENT:
burning or stinging upon instillation, dry eyes, hearing disturbances,
photophobia, tinnitus, visual disturbances
-
GI:
abdominal cramps, constipation, diarrhea, dyspepsia, flatulence,
gastric or duodenal ulcer with bleeding or perforation, hepatitis,
nausea, occult blood in stool, pancreatitis, vomiting
-
GU:
renal failure
-
HEME:
agranulocytosis, eosinophilia, leukopenia, pancytopenia,
thrombocytopenia
-
METAB:
hyperglycemia, hyperkalemia, hypoglycemia, hyponatremia,
-
RESP:
bronchospasm, dyspnea
-
SKIN:
photosensitivity, rash, urticaria
|
Dosage:
Drug
interactions:
-
Warfarin:
addition of flurbiprofen associated with excessive hypoprothrombinemia
and bleeding; ibuprofen less likely to interact
-
Methotrexate:
addition of flurbiprofen may interfere with the renal secretion of
methotrexate, yielding increased risk of methotrexate toxicity
-
Prednisone:
increase risk of GI ulceration
-
Loop
diuretics: reduction in diuretic and antihypertensive effects
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|